544 related articles for article (PubMed ID: 15761494)
1. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
[TBL] [Abstract][Full Text] [Related]
2. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
[TBL] [Abstract][Full Text] [Related]
3. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
[TBL] [Abstract][Full Text] [Related]
4. Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.
Wang E; Hsieh-Li HM; Chiou YY; Chien YL; Ho HH; Chin HJ; Wang CK; Liang SC; Jiang ST
J Pathol; 2010 Nov; 222(3):238-48. PubMed ID: 20814903
[TBL] [Abstract][Full Text] [Related]
5. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.
Lu W; Peissel B; Babakhanlou H; Pavlova A; Geng L; Fan X; Larson C; Brent G; Zhou J
Nat Genet; 1997 Oct; 17(2):179-81. PubMed ID: 9326937
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of PKD1 causes polycystic kidney disease.
Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Coté O; Trudel M
Mol Cell Biol; 2006 Feb; 26(4):1538-48. PubMed ID: 16449663
[TBL] [Abstract][Full Text] [Related]
7. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
[TBL] [Abstract][Full Text] [Related]
8. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.
Nauli SM; Rossetti S; Kolb RJ; Alenghat FJ; Consugar MB; Harris PC; Ingber DE; Loghman-Adham M; Zhou J
J Am Soc Nephrol; 2006 Apr; 17(4):1015-25. PubMed ID: 16565258
[TBL] [Abstract][Full Text] [Related]
9. Altered Hippo signalling in polycystic kidney disease.
Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
[TBL] [Abstract][Full Text] [Related]
12. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
14. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures.
Elberg G; Guruswamy S; Logan CJ; Chen L; Turman MA
Cell Tissue Res; 2008 Feb; 331(2):495-508. PubMed ID: 18004594
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene.
Boulter C; Mulroy S; Webb S; Fleming S; Brindle K; Sandford R
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12174-9. PubMed ID: 11593033
[TBL] [Abstract][Full Text] [Related]
16. Depletion of PKD1 by an antisense oligodeoxynucleotide induces premature G1/S-phase transition.
Kim H; Bae Y; Jeong W; Ahn C; Kang S
Eur J Hum Genet; 2004 Jun; 12(6):433-40. PubMed ID: 15054393
[TBL] [Abstract][Full Text] [Related]
17. The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia.
Wilson PD; Geng L; Li X; Burrow CR
Lab Invest; 1999 Oct; 79(10):1311-23. PubMed ID: 10532593
[TBL] [Abstract][Full Text] [Related]
18. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
[TBL] [Abstract][Full Text] [Related]
19. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
Lanoix J; D'Agati V; Szabolcs M; Trudel M
Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
